Hostname: page-component-76fb5796d-25wd4 Total loading time: 0 Render date: 2024-04-26T05:11:27.405Z Has data issue: false hasContentIssue false
  • English
  • Français

Wernicke encephalopathy without delirium in patients with cancer

Published online by Cambridge University Press:  03 May 2017

Hideki Onishi ,
Mayumi Ishida ,
Iori Tanahashi ,
Takao Takahashi ,
Yoshitada Taji ,
Kenji Ikebuchi ,
Daisuke Furuya  and
Tatsuo Akechi
Hideki Onishi*
Affiliation:
Department of Psycho-Oncology, Saitama Medical University, Saitama International Medical Center, Saitama, Japan
Mayumi Ishida
Affiliation:
Department of Psycho-Oncology, Saitama Medical University, Saitama International Medical Center, Saitama, Japan
Iori Tanahashi
Affiliation:
Department of Psycho-Oncology, Saitama Medical University, Saitama International Medical Center, Saitama, Japan
Takao Takahashi
Affiliation:
Department of Palliative Medicine, Saitama Medical University, Saitama International Medical Center, Saitama, Japan
Yoshitada Taji
Affiliation:
Department of Laboratory Medicine, Saitama Medical University, Saitama International Medical Center, Saitama, Japan
Kenji Ikebuchi
Affiliation:
Department of Laboratory Medicine, Saitama Medical University, Saitama International Medical Center, Saitama, Japan
Daisuke Furuya
Affiliation:
Department of General Medicine, Saitama Medical University, Saitama International Medical Center, Saitama, Japan
Tatsuo Akechi
Affiliation:
Department of Psychiatry and Cognitive-Behavioral Medicine, Graduate School of Medical Sciences, Nagoya City University, Nagoya, Japan
*
Address correspondence and reprint requests to: Hideki Onishi, Department of Psycho-Oncology, Saitama Medical University, Saitama International Medical Center, 1397-1 Yamane, Hidaka City, Saitama 350-1298, Japan. E-mail: honishi@saitama-med.ac.jp.
Get access Rights & Permissions [Opens in a new window]

Abstract

Objective:

Wernicke encephalopathy (WE) is a neuropsychiatric disorder caused by thiamine deficiency. Several reports of WE in cancer patients are known. WE is sometimes overlooked because most patients do not exhibit its typical symptoms (e.g., delirium, ataxia, ocular palsy). If delirium is not present, a diagnosis of WE is difficult because delirium is the hallmark symptom of WE.

Method:

Taken from a series on WE in cancer, we report two patients who developed WE without delirium during periodic psycho-oncology outpatient visits.

Results:

Case 1. A 61-year-old woman with non-Hodgkin lymphoma who was periodically attending a psycho-oncology outpatient clinic developed an unsteady gait. WE was suspected because she also developed appetite loss for two weeks, and we could find no other laboratory findings to explain her unsteady gait. Our diagnosis was supported by abnormal serum thiamine and disappearance of the gait disturbance after intravenous thiamine administration. Case 2. A 50-year-old woman with breast carcinoma with bone metastasis developed an unsteady gait. WE was suspected because she also developed loss of appetite for two weeks, and no other laboratory findings could explain her unsteady gait. The diagnosis was supported by abnormal serum thiamine and disappearance of the gait disturbance after administration of intravenous thiamine.

Significance of Results:

Our report emphasizes the importance of being aware of WE, even when patients do not present with delirium. The presence of loss of appetite for more than two weeks may be the key to a diagnosis of WE.

Keywords

Wernicke encephalopathyDeliriumCancerThiamine deficiencyVitamin B1
Type
Case Report
Information
Palliative & Supportive Care , Volume 16 , Special Issue 1: Special Instruments – Assessment and Measure Issues in Palliative Care , February 2018 , pp. 118 - 121
Copyright
Copyright © Cambridge University Press 2017 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

REFERENCES

American Psychiatric Association (2013). Diagnostic and Statistical Manual of Mental Disorders, 5th ed. Washington, DC: American Psychiatric Association Publishing.Google Scholar
Harper, C.G., Giles, M. & Finlay-Jones, R. (1986). Clinical signs in the Wernicke–Korsakoff complex: A retrospective analysis of 131 cases diagnosed at necropsy. Journal of Neurology, Neurosurgery, and Psychiatry, 49(4), 341–345. Available from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1028756/.CrossRefGoogle ScholarPubMed
Hoyumpa, A.M. Jr. (1980). Mechanisms of thiamin deficiency in chronic alcoholism. The American Journal of Clinical Nutrition, 33(12), 2750–2761.Google Scholar
Isenberg-Grzeda, E., Kutner, H.E. & Nicolson, S.E. (2012). Wernicke–Korsakoff syndrome: Under-recognized and under-treated. Psychosomatics, 53(6), 507–516.CrossRefGoogle ScholarPubMed
Isenberg-Grzeda, E., Alici, Y., Hatzoglou, V., et al. (2016 a). Nonalcoholic thiamine-related encephalopathy (Wernicke–Korsakoff syndrome) among inpatients with cancer: A series of 18 cases. Psychosomatics, 57(1), 71–81. Epub ahead of print Oct 23, 2015. Available from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4979979/.CrossRefGoogle Scholar
Isenberg-Grzeda, E., Rahane, S., DeRosa, A.P., et al. (2016 b). Wernicke–Korsakoff syndrome in patients with cancer: A systematic review. The Lancet. Oncology, 17(4), e142–e148.CrossRefGoogle ScholarPubMed
Kneis, S., Wehrle, A., Freyler, K., et al. (2016). Balance impairments and neuromuscular changes in breast cancer patients with chemotherapy-induced peripheral neuropathy. Clinical Neurophysiology, 127(2), 1481–1490. Epub ahead of print Aug 14, 2015.CrossRefGoogle ScholarPubMed
MacLean, L.D., Rhode, B.M. & Shizgal, H.M. (1983). Nutrition following gastric operations for morbid obesity. Annals of Surgery, 198(3), 347–355. Available from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1353306/pdf/annsurg00127-0117.pdf.Google Scholar
Manzo, L., Locatelli, C., Candura, S.M., et al. (1994). Nutrition and alcohol neurotoxicity. Neurotoxicology, 15(3), 555–565.Google ScholarPubMed
Onishi, H., Kawanishi, C., Onose, M., et al. (2004). Successful treatment of Wernicke encephalopathy in terminally ill cancer patients: Report of three cases and a review of the literature. Supportive Care in Cancer, 12(8), 604–608. Epub ahead of print May 13.CrossRefGoogle Scholar
Onishi, H., Sugimasa, Y., Kawanishi, C., et al. (2005). Wernicke encephalopathy presented in the form of postoperative delirium in a patient with hepatocellular carcinoma and liver cirrhosis: A case report and review of the literature. Palliative & Supportive Care, 3(4), 337–340.CrossRefGoogle Scholar
Onishi, H., Ishida, M., Toyama, H., et al. (2016). Early detection and successful treatment of Wernicke encephalopathy in a patient with advanced carcinoma of the external genitalia during chemotherapy. Palliative & Supportive Care, 14(3), 302–306. Epub ahead of print Dec 11, 2015.Google Scholar
Sechi, G. & Serra, A. (2007). Wernicke's encephalopathy: New clinical settings and recent advances in diagnosis and management. The Lancet. Neurology, 6(5), 442–455.CrossRefGoogle ScholarPubMed
Sechi, G., Batzu, L., Agro, L., et al. (2016). Cancer-related Wernicke–Korsakoff syndrome. The Lancet. Oncology, 17(6), e221–222. Available from http://www.thelancet.com/pdfs/journals/lanonc/PIIS1470-2045(16)30109-7.pdf.CrossRefGoogle ScholarPubMed
Yae, S., Okuno, S., Onishi, H., et al. (2005). Development of Wernicke encephalopathy in a terminally ill cancer patient consuming an adequate diet: A case report and review of the literature. Palliative & Supportive Care, 3(4), 333–335.Google Scholar